STAT October 19, 2020
The Centers for Medicare and Medicaid Services (CMS) recently issued a draft rule that could dramatically improve access to evidence-based treatments that can be delivered virtually. But it won’t unless CMS makes another seemingly simple change regarding benefit categories.
Covid-19 has killed more than 180,000 Medicare beneficiaries to date, representing about 80% of all Covid-19 deaths in the U.S. That means there’s a pressing need for safe and effective socially distanced digital therapeutics.
The Medicare Coverage for Innovative Technology (MCIT) proposed rule would cover the use of medical devices designated as “breakthrough” technologies as soon as they are approved by the U.S. Food and Drug Administration. That represents a big change: These technologies are currently reviewed and approved by the...
Today's Sponsors
Today's Sponsor